Study to Assess the Safety, Tolerability, PK and PD of ABX1100

Clinical trial NCT06109948 · COMPLETED

Trial details

NCT number: NCT06109948
Sponsor: Aro Biotherapeutics
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Late Onset Pompe Disease

Start date: 2023-10-19
Primary completion: 2026-02-13
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.